Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $344.57 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $227.46 | 3 | $0 (2017) |
| BOSTON SCIENTIFIC CORPORATION | $75.55 | 1 | $0 (2017) |
| Genentech USA, Inc. | $41.56 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $29.98 | 2 | Genentech USA, Inc. ($29.98) |
| 2020 | $11.58 | 1 | Genentech USA, Inc. ($11.58) |
| 2017 | $303.01 | 4 | Daiichi Sankyo Inc. ($227.46) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Virology & Specialty Care | ||||||
| 01/26/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Virology & Specialty Care | ||||||
| 11/30/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.58 | General |
| Category: Virology & Specialty Care | ||||||
| 10/31/2017 | BOSTON SCIENTIFIC CORPORATION | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $75.55 | General |
| Category: STRUCTURAL HEART | ||||||
| 06/12/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $110.96 | General |
| Category: Opioid Induced Constipation | ||||||
| 06/12/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: Opioid Induced Constipation | ||||||
| 03/01/2017 | Daiichi Sankyo Inc. | Movantik (Drug) | Food and Beverage | In-kind items and services | $109.15 | General |
| Category: Opioid Induced Constipation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 553 | 599 | $127,640 | $35,333 |
| 2022 | 11 | 776 | 861 | $184,019 | $58,360 |
| 2021 | 10 | 709 | 765 | $177,226 | $54,345 |
| 2020 | 8 | 311 | 316 | $67,860 | $22,258 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 102 | $32,130 | $10,927 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 104 | $32,760 | $7,847 | 24.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 82 | 82 | $25,830 | $7,163 | 27.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 116 | 120 | $18,000 | $4,154 | 23.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 29 | 29 | $9,135 | $1,659 | 18.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,780 | $1,601 | 42.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 57 | 61 | $3,050 | $988.20 | 32.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 30 | 57 | $1,995 | $924.54 | 46.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 30 | 32 | $960.00 | $70.40 | 7.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 135 | 145 | $45,675 | $17,822 | 39.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 99 | 99 | $31,185 | $9,430 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 67 | $21,105 | $6,451 | 30.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 140 | 151 | $22,650 | $6,277 | 27.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 83 | 95 | $29,925 | $5,973 | 20.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 79 | 87 | $8,700 | $4,428 | 50.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 49 | 49 | $15,435 | $3,983 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,339 | $1,820 | 54.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 44 | 87 | $3,045 | $1,417 | 46.5% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 43 | 43 | $2,150 | $700.33 | 32.6% |
| 81003 | Automated urinalysis test | Office | 2022 | 27 | 27 | $810.00 | $59.69 | 7.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 176 | 202 | $63,630 | $19,100 | 30.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 187 | 207 | $20,700 | $10,621 | 51.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 113 | 113 | $35,595 | $9,071 | 25.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 78 | 84 | $26,460 | $5,295 | 20.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 44 | 44 | $13,750 | $4,251 | 30.9% |
About Dr. Arvind Patel, M.D
Dr. Arvind Patel, M.D is a Internal Medicine healthcare provider based in Piscataway, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386653319.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arvind Patel, M.D has received a total of $344.57 in payments from pharmaceutical and medical device companies, with $29.98 received in 2021. These payments were reported across 7 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($344.57).
As a Medicare-enrolled provider, Patel has provided services to 2,349 Medicare beneficiaries, totaling 2,541 services with total Medicare billing of $170,297. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Piscataway, NJ
- Active Since 08/07/2006
- Last Updated 05/28/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386653319
Products in Payments
- Movantik (Drug) $227.46
- WATCHMAN (Device) $75.55
- Xofluza (Drug) $41.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Piscataway
Dr. Julio Hip-Flores, M.d, M.D
Internal Medicine — Payments: $8,753
Howard Kipen, Md, MD
Internal Medicine — Payments: $5,625
Dr. Alieta Eck, M.d, M.D
Internal Medicine — Payments: $2,198
Dr. Archna Parmar, D.o, D.O
Internal Medicine — Payments: $1,932
Jing Niu, M.d, M.D
Internal Medicine — Payments: $721.83
Dr. Cecil Mathews, Md, MD
Internal Medicine — Payments: $424.59